1-3 of 3
Sandra Wille, PhD
Close
Sort by
Journal Articles

A Comprehensive Deep-Sequencing Study of Blast Crisis Chronic Myeloid Leukemia (CML) Reveals New Insights Into Molecular Heterogeneity and Detects Mutations In 12 Different Genes In 82.5% of Cases

Vera Grossmann, MA, Christiane Eder, PhD, Sonja Schindela, Alexander Kohlmann, PhD, Sandra Wille, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Martin C. Mùˆller, Andreas Hochhaus, MD, Torsten Haferlach, MD, Claudia Haferlach, MD
Journal: Blood
Blood (2010) 116 (21): 884.
https://doi.org/10.1182/blood.V116.21.884.884
Published: 2010
Journal Articles

FISH Analysis In 843 Cases with Myeloid Malignancies Revealed TET2 deletions In 6% of Patients Which Were Accompanied by TET2 Mutations In 51% of Cases

Claudia Haferlach, MD, Sandra Wille, PhD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD
Journal: Blood
Blood (2010) 116 (21): 1706.
https://doi.org/10.1182/blood.V116.21.1706.1706
Published: 2010
Journal Articles

Landscape of TET2 Mutations In Acute Myeloid Leukemia (AML): A Next-Generation Sequencing Study Investigating 76 Cases Comprehensively Characterized for Cytogenetics and Other Molecular Markers.

Sandra Wille, PhD, Vera Grossmann, MA, Tamara Alpermann, Claudia Haferlach, MD, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Alexander Kohlmann, PhD
Journal: Blood
Blood (2010) 116 (21): 1035.
https://doi.org/10.1182/blood.V116.21.1035.1035
Published: 2010